The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model
Open accessAbstract
Mesenchymal stem cells (MSC) were reported to ameliorate functional deficits after stroke in rats, with some of this improvement possibly resulting from the action of cytokines secreted by these cells. To enhance such cytokine effects, we previously transfected the telomerized human MSC with the BDNF gene using a fiber-mutant adenovirus vector and reported that such treatment contributed to improved ischemic recovery in a rat transient middle cerebral artery occlusion (MCAO) model. In the present study, we investigated whether other cytokines in addition to BDNF, i.e., GDNF, CNTF, or NT3, might have a similar or greater effect in this model. Rats that received MSC-BDNF (P < 0.05) or MSC-GDNF (P < 0.05) showed significantly more functional recovery as demonstrated by improved behavioral test results and reduced ischemic damage on MRI than did control rats 7 and 14 days following MCAO. On the other hand, rats that received MSC-CNTF or MSC-NT3 showed neither functional recovery nor ischemic damage reduction compared to control rats. Thus, MSC transfected with the BDNF or GDNF gene resulted in improved function and reduced ischemic damage in a rat model of MCAO. These data suggest that gene-modified cell therapy may be a useful approach for the treatment of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Bone Marrow as a Potential Source of Hepatic Oval Cells
Petersen, B. E., Bowen, W. C., Patrene, K. D., Mars, W. M., Sullivan, A. K., Murase, N., Boggs, S. S., Greenberger, J. S., & Goff, J. P. (1999) · Science · doi:10.1126/science.284.5417.1168 · Cited by 2,378
Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro
Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T. B., Saporta, S., Janssen, W., Patel, N., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7389 · Cited by 1,562
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
Hefti, F. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,450
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
Lamballe, F., Klein, R., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90442-2 · Cited by 1,080
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
Induction of Apoptosis by the Low-Affinity NGF Receptor
Rabizadeh, S., Oh, J., Zhong, L.-T., Yang, J., Bitler, C. M., Butcher, L. L., & Bredesen, D. E. (1993) · Science · doi:10.1126/science.8332899 · Cited by 782
Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9706-9713.1998 · Cited by 767
Cited by
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Siegel, G., Kluba, T., Hermanutz-Klein, U., Bieback, K., Northoff, H., & Schäfer, R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-146 · Cited by 493
Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration
Kode, J. A., Mukherjee, S., Joglekar, M. V., & Hardikar, A. A. (2009) · Cytotherapy · doi:10.1080/14653240903080367 · Cited by 384
Angiogenesis after cerebral ischemia
Beck, H., & Plate, K. H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0483-6 · Cited by 383
François, S., Bensidhoum, M., Mouiseddine, M., Mazurier, C., Allenet, B., Semont, A., Frick, J., Saché, A., Bouchet, S., Thierry, D., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0260 · Cited by 382
Cell transplantation therapy for stroke
Bliss, T., Guzman, R., Daadi, M., & Steinberg, G. K. (2007) · Stroke · doi:10.1161/01.str.0000247888.25985.62 · Cited by 374
Wei, L., Fraser, J. L., Lu, Z.-Y., Hu, X., & Yu, S. P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.002 · Cited by 358
Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 354
Stem cells in the umbilical cord
Weiss, M. L., & Troyer, D. L. (2006) · Stem Cell Reviews · doi:10.1007/s12015-006-0022-y · Cited by 344
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice
Zhang, J., Li, Y., Chen, J., Cui, Y., Lu, M., Elias, S. B., Mitchell, J. B., Hammill, L., Vanguri, P., & Chopp, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.03.018 · Cited by 341
Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?
Teixeira, F. G., Carvalho, M. M., Sousa, N., & Salgado, A. J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1290-8 · Cited by 330
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
Vercelli, A., Mereuta, O. M., Garbossa, D., Muraca, G., Mareschi, K., Rustichelli, D., Ferrero, I., Mazzini, L., Madon, E., & Fagioli, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.016 · Cited by 309
Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements
Doorn, J., Moll, G., Le Blanc, K., van Blitterswijk, C., & de Boer, J. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0488 · Cited by 307
Human Mesenchymal Stem Cells Efficiently Manage Oxidative Stress
Valle-Prieto, A., & Conget, P. A. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0093 · Cited by 302
Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy
Ikegame, Y., Yamashita, K., Hayashi, S.-I., Mizuno, H., Tawada, M., You, F., Yamada, K., Tanaka, Y., Egashira, Y., Nakashima, S., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2010.549122 · Cited by 293
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
Liu, H. (2006) · Brain · doi:10.1093/brain/awl207 · Cited by 291
BNIP3 Interacting with LC3 Triggers Excessive Mitophagy in Delayed Neuronal Death in Stroke
Shi, R., Zhu, S., Li, V., Gibson, S. B., Xu, X., & Kong, J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12325 · Cited by 279
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242
Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008) · Cytotherapy · doi:10.1080/14653240802486517 · Cited by 128
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, H., Alam, A., San, C.-Y., Eguchi, S., Chen, Q., Lian, Q., & Ma, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.029 · Cited by 122
Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
Wang, F., Tang, H., Zhu, J., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795424 · Cited by 102
Xin, H., Li, Y., Shen, L. H., Liu, X., Wang, X., Zhang, J., Pourabdollah-Nejad D, S., Zhang, C., Zhang, L., Jiang, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009027 · Cited by 101
Neurotrophic Factors and Their Potential Applications in Tissue Regeneration
Xiao, N., & Le, Q.-T. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0376-4 · Cited by 93
Neuroprotective Effect of Human Placenta-Derived Cell Treatment of Stroke in Rats
Chen, J., Shehadah, A., Pal, A., Zacharek, A., Cui, X., Cui, Y., Roberts, C., Lu, M., Zeitlin, A., Hariri, R., et al. (2013) · Cell Transplantation · doi:10.3727/096368911x637380 · Cited by 70
“MSCs transfected with the BDNF or GDNF gene improves neurological function and reduces ischemic damage in a rat model of MCAo (23).”
Background
Metadata
- Authors
- Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Ishii, K., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., Honmou, O., Houkin, K., Date, I., & Hamada, H.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 11
- Issue
- 1
- Pages
- 96-104
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2020709967
- Cited by
- 398
- References
- 49
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.